Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise
Shanghai Fosun Pharmaceutical (Group) (HKG:2196) signed a Share Subscription Agreement with IFC and ADB to invest 270 million yuan each in United Health Insurance, according to a Monday filing with the Hong Kong bourse.
The deal will increase Fosun Pharma's stake in the insurer from 14.00% to 20.05%. The capital infusion, totaling 810 million yuan, will support the company's expansion. The transaction does not require the approval of independent shareholders.
Fosun Pharma views this investment as a strategic move to enhance its presence in China's rapidly growing health insurance sector.
The pharmaceuticals shares were up 6% in Hong Kong and 4% in Shanghai in recent trading.
Comments